Interestingly, the MUC1-Vax-DCs vaccine group was significantly more effective than the PDL1-DCs vaccine group in inducing anti-tumor humoral and cellular immune responses and inhibiting tumor cell growth, and had a stronger inhibitory effect on pancreatic and lung cancer cell growth, and the survival time of mice in this group was also longer. The gene discussed is MUC1; the disease is lung cancer.